News
FDA Appoints Biotech Exec
Digest more
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
The president's proposed budget cuts to the NIH would eventually result in fewer drugs on the market, the U.S. Congressional ...
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
"ICE will now become the country’s largest federal law enforcement agency, bigger than the FBI, bigger than the DEA," former ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
In the first six months of 2025, 385 employees resigned from the Center for Drug Evaluation and Research, compared with under 130 staff during the same period last year.
Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public ...
HHS faces other legal challenges over its workforce cuts. A class-action lawsuit in the U.S. Court for the District of Columbia claims the department relied on “hopelessly error-ridden” data when it ...
The Department of Health and Human Services (HHS) is laying off certain employees who were notified months ago of the ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback